This is just a tiny glimpse of the data available to CivicScience clients. Discover more data.
CivicScience has data on over 170K current GLP-1 users, providing a unique lens into these medications’ societal, cultural, and economic impact. Each month, we deliver key data exploring how GLP-1 users are influencing a wide range of industries, including healthcare, retail, food service, fitness, and apparel. Here’s a glimpse of our latest GLP-1 data – discover how you can access the full dataset here.
1. One-half of GLP-1 users plan to stay on the medication either long-term or indefinitely. Here’s why it matters for brands.
CivicScience data from early January show that nearly one in five U.S. adults are either currently using or considering a GLP-1 drug for weight loss. Many users expect to stay on the medication long-term, with half planning to take it for at least one to five years or indefinitely. This sustained usage could have lasting implications for brands, as additional data reveal shifts in daily habits. For example, just under two in five of current users report drinking less alcohol and dining out less since starting a GLP-1 drug. Conversely, GLP-1 users have become more likely to exercise, sleep longer, attend medical appointments, and take vitamins/supplements.
Answer our Poll: Would you take Ozempic or another GLP-1 medication in the future?
2. Over the past three months, GLP-1 users were much more likely than lookalike respondents to plan on buying dress shirts, sweaters/pullovers, and shorts.
During Q4 2024, CivicScience reported that nearly two-thirds of current GLP-1 users were adjusting their shopping habits since starting the medication. This included buying smaller, more “edgy” clothing and trying new brands. Now, our most recent data shows which types of clothing current GLP-1 users are most likely to buy – over the last three months, they were much more likely than a lookalike segment (U.S. adults with the same age and gender distribution who consider themselves overweight but not using a GLP-1 medication) to plan on purchasing dress shirts, sweaters/pullovers, and shorts.
3. GLP-1 users are upping their spending on groceries and clothing.
Recent reports suggest that GLP-1 drugs could have a significant economic impact in 2025. CivicScience data support this, finding that current GLP-1 users are increasing their spending across multiple categories. Grocery spending sees the highest potential increase, followed by clothing, which has experienced the largest growth since Q3 2024.
Take our Poll: Would you consider taking a prescription weight loss drug?
As the GLP-1 landscape evolves, understanding its wide-ranging societal impacts is more important than ever. CivicScience’s GLP-1 consumer data provides invaluable insights into how these medications are transforming consumer behavior and influencing various industries in real-time.
